Parkinson Disease and Exercise Snacks
Launched by UNIVERSITY OF BRITISH COLUMBIA · Mar 31, 2025
Trial Information
Current as of July 24, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial, called "Parkinson Disease and Exercise Snacks," is studying a new way to help people with Parkinson's Disease (PD) stay active. The researchers want to see if short bursts of exercise, which they call "exercise snacks," can make it easier for individuals to incorporate physical activity into their daily lives. These snacks are quick, vigorous activities that don’t require special equipment and can be done anywhere, making it more accessible for those who may struggle with traditional exercise due to fatigue or mobility issues.
To participate in this study, you need to be an adult (19 years or older) with a confirmed diagnosis of Parkinson's Disease and have the approval of your doctor to exercise. You should also be able to move independently, at least to some degree, and have access to a computer, tablet, or smartphone with internet for tracking your progress. Unfortunately, if you have other health conditions that limit your ability to exercise, or if you're using a walker or cane, you might not be eligible. Participants will engage in these short exercise sessions and help the researchers learn how effective and feasible this approach is for future studies. This trial is not yet recruiting, but it aims to pave the way for broader research on improving activity levels in people with Parkinson's Disease.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adults (19 years of age or older) with Clinically Established PD (Postuma et al., 2015).
- • Medically cleared to exercise by their physician.
- • A score of ≤3 on the modified Hoehn \& Yahr scale (i.e. physically independent, may have unilateral or bilateral clinical signs, including mild impairment of postural reflexes).
- • Have access to a computer, tablet, or smartphone with internet connection for intervention delivery and tracking.
- • Exclusion criteria
- • Comorbid condition with physical disability preventing participation in exercise (i.e., that cannot be accommodated with modifications to the prescribed exercise).
- • A score of \>=4 on the modified Hoehn \& Yahr scale (meaning they may be able to stand or walk but are not physically independent; this typically includes a need for gait aids such as a cane or walker)
- • No access to reliable internet connection.
- • Are currently participating in another clinical trial that would interfere with the study procedures described.
- • Have a scheduled event (e.g. medical or surgical procedure, prolonged travel in the next 3-4 months) that would interrupt participation in the study.
About University Of British Columbia
The University of British Columbia (UBC) is a leading research institution located in Vancouver, Canada, renowned for its commitment to advancing health sciences through innovative research and education. As a prominent clinical trial sponsor, UBC leverages its interdisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical studies aimed at improving patient outcomes across various medical fields. The university fosters collaborations with healthcare professionals, industry partners, and community stakeholders to translate research findings into practical applications, thereby contributing to the global advancement of medicine and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kelowna, British Columbia, Canada
Patients applied
Trial Officials
Daryl J Wile, MD
Principal Investigator
University of British Columbia
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported